Form 4 for FHTX Foghorn Therapeutics Inc.
Accepted 2023-08-18 00:00:00 ET · period of report 2023-08-16 · accession 0001562180-23-006433 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-18 | 2023-08-16 | FHTX | Agresta Samuel | Chief Medical Off | M - OptEx | $3.72 | +311.3K | 311.3K | New | +$1.16M |
| D | 2023-08-18 | 2023-08-16 | FHTX | Agresta Samuel | Chief Medical Off | S - Sale+OE | $8.25 | -311.3K | 0 | -100% | -$2.57M |
| D | 2023-08-18 | 2023-08-16 | FHTX | Agresta Samuel | Chief Medical Off | M - OptEx | $0.00 | -311.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-16 | M | A | 311,297 | $3.72 | 311,297 | D | — | — | |
| 2 | Common | Common Stock | 2023-08-16 | S | D | 311,297 | $8.25 | 0 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2023-08-16 | M | D | 311,297 | $0.00 | 0 | D | $3.72 · — to 2029-09-16 | 311,297 Common Stock | (F1) The option vested as to 25% of the underlying shares of common stock on September 16, 2020, the first anniversary of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter until fully vested. |